New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myelomaSarclisa SC formulation added to ...

Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...

In the ever-evolving world of weight loss supplements, AquaSculpt has emerged as a game-changer, captivating the attention of ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

They watched peers juggle small kids, frantic careers, ageing parents. Determined to find a solution to a problem facing the ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and ...

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

EXTON, PA / ACCESSWIRE / January 6, 2025 / Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the C ...

The best dog food of 2025 includes wet, dry and grain-free dog food from brands like Purina, Royal Canin, The Farmer's Dog, ...

There’s always a mix of excitement and doubt when it comes to weight loss supplements. With so many options out there, each ...

Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...